Baker Bros. Advisors’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29M | Buy |
689,488
+357,955
| +108% | +$15.1M | 0.28% | 32 |
|
|
2025
Q1 | $12.6M | Hold |
331,533
| – | – | 0.14% | 41 |
|
|
2024
Q4 | $25.5M | Buy |
331,533
+8,428
| +3% | +$649K | 0.27% | 40 |
|
|
2024
Q3 | $18.6M | Buy |
323,105
+191,572
| +146% | +$11M | 0.19% | 44 |
|
|
2024
Q2 | $5.44M | Hold |
131,533
| – | – | 0.07% | 62 |
|
|
2024
Q1 | $8.03M | Hold |
131,533
| – | – | 0.1% | 55 |
|
|
2023
Q4 | $2.93M | Buy |
131,533
+6,205
| +5% | +$138K | 0.03% | 68 |
|
|
2023
Q3 | $3.21M | Hold |
125,328
| – | – | 0.02% | 74 |
|
|
2023
Q2 | $2.16M | Hold |
125,328
| – | – | 0.01% | 93 |
|
|
2023
Q1 | $1.52M | Buy |
125,328
+3,307
| +3% | +$40.1K | 0.01% | 95 |
|
|
2022
Q4 | $4.36M | Buy |
+122,021
| New | +$4.36M | 0.03% | 80 |
|